Cargando…

Mobile Breast Cancer e-Support Program for Chinese Women With Breast Cancer Undergoing Chemotherapy (Part 3): Secondary Data Analysis

BACKGROUND: Many app-based interventions targeting women with breast cancer have been developed and tested for effectiveness. However, information regarding the evaluation of the usage of these interventions is scarce. A better understanding of usage data is important to determine how women use apps...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Haihua, Chen, Xiuwan, Yang, Jinqiu, Wu, Qiaoling, Zhu, Jiemin, Chan, Sally Wai-Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527913/
https://www.ncbi.nlm.nih.gov/pubmed/32936087
http://dx.doi.org/10.2196/18896
_version_ 1783589155550265344
author Zhu, Haihua
Chen, Xiuwan
Yang, Jinqiu
Wu, Qiaoling
Zhu, Jiemin
Chan, Sally Wai-Chi
author_facet Zhu, Haihua
Chen, Xiuwan
Yang, Jinqiu
Wu, Qiaoling
Zhu, Jiemin
Chan, Sally Wai-Chi
author_sort Zhu, Haihua
collection PubMed
description BACKGROUND: Many app-based interventions targeting women with breast cancer have been developed and tested for effectiveness. However, information regarding the evaluation of the usage of these interventions is scarce. A better understanding of usage data is important to determine how women use apps and how these interventions affect health outcomes. OBJECTIVE: This study aimed to examine the usage duration and login frequency of an app-based intervention, the Breast Cancer e-Support (BCS) program, and to investigate the association between usage data and participants’ demographic and medical characteristics. METHODS: This study is a secondary data analysis of a randomized controlled trial assessing the effectiveness of the BCS program. The BCS program contains four modules: Learning Forum, Discussion Forum, Ask-the-Expert Forum, and Your Story Forum. A total of 57 women in the intervention group accessed the BCS program during their 12-week chemotherapy. The app’s background system tracked the usage duration and login frequency for each forum and the entire BCS program. RESULTS: The total usage duration per participant ranged from 0 to 9371 minutes, and the login frequency per participant ranged from 0 to 774 times. The Discussion Forum and the Learning Forum were the most frequently used modules. The general linear model showed that age, education, family monthly income, and employment were associated with BCS usage duration and/or login frequency. Age (F(1,45)=10.09, P=.003, B=115.34, 95% CI 42.22-188.47) and education level (F(1,45)=7.22, P=.01, B=1949.63, 95% CI 487.76-3411.50) were positively associated with the usage duration of the entire BCS program. Family monthly income was positively associated with the usage duration of the Learning Forum (F(1,45)=11.85, P=.001, B=1488.55, 95% CI 617.58-2359.51) and the login frequency of the entire BCS program (F(1,45)=4.47, P=.04, B=113.68, 95% CI 5.33-222.03). Employment was negatively associated with the usage duration of the Ask-the-expert Forum (F(1,45)=4.50, P=.04, B=–971.87, 95% CI –1894.66 to –49.07) and the Your Story Forum (F(1,45)=5.36, P=.03, B=–640.71, 95% CI –1198.30 to –83.11) and positively associated with the login frequency of the entire BCS program (F(1,45)=10.86, P=.002, B=192.88, 95% CI 75.01-310.74). No statistical differences were found between BCS usage data and cancer stage, BMI, comorbidity, types of surgery, or cycles of chemotherapy. CONCLUSIONS: Overall, this study found considerable variability in the usage of app-based interventions. When health care professionals incorporate app-based interventions into their routine care for women with breast cancer, the learning and discussion functions of apps should be strengthened to promote engagement. Additionally, characteristics of women with breast cancer, such as age, level of education, income, and employment status, should be taken in consideration to develop tailored apps that address their particular needs and therefore improve their engagement with the app. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry ACTRN12616000639426; http://www.ANZCTR.org.au/ACTRN12616000639426.aspx
format Online
Article
Text
id pubmed-7527913
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-75279132020-10-15 Mobile Breast Cancer e-Support Program for Chinese Women With Breast Cancer Undergoing Chemotherapy (Part 3): Secondary Data Analysis Zhu, Haihua Chen, Xiuwan Yang, Jinqiu Wu, Qiaoling Zhu, Jiemin Chan, Sally Wai-Chi JMIR Mhealth Uhealth Original Paper BACKGROUND: Many app-based interventions targeting women with breast cancer have been developed and tested for effectiveness. However, information regarding the evaluation of the usage of these interventions is scarce. A better understanding of usage data is important to determine how women use apps and how these interventions affect health outcomes. OBJECTIVE: This study aimed to examine the usage duration and login frequency of an app-based intervention, the Breast Cancer e-Support (BCS) program, and to investigate the association between usage data and participants’ demographic and medical characteristics. METHODS: This study is a secondary data analysis of a randomized controlled trial assessing the effectiveness of the BCS program. The BCS program contains four modules: Learning Forum, Discussion Forum, Ask-the-Expert Forum, and Your Story Forum. A total of 57 women in the intervention group accessed the BCS program during their 12-week chemotherapy. The app’s background system tracked the usage duration and login frequency for each forum and the entire BCS program. RESULTS: The total usage duration per participant ranged from 0 to 9371 minutes, and the login frequency per participant ranged from 0 to 774 times. The Discussion Forum and the Learning Forum were the most frequently used modules. The general linear model showed that age, education, family monthly income, and employment were associated with BCS usage duration and/or login frequency. Age (F(1,45)=10.09, P=.003, B=115.34, 95% CI 42.22-188.47) and education level (F(1,45)=7.22, P=.01, B=1949.63, 95% CI 487.76-3411.50) were positively associated with the usage duration of the entire BCS program. Family monthly income was positively associated with the usage duration of the Learning Forum (F(1,45)=11.85, P=.001, B=1488.55, 95% CI 617.58-2359.51) and the login frequency of the entire BCS program (F(1,45)=4.47, P=.04, B=113.68, 95% CI 5.33-222.03). Employment was negatively associated with the usage duration of the Ask-the-expert Forum (F(1,45)=4.50, P=.04, B=–971.87, 95% CI –1894.66 to –49.07) and the Your Story Forum (F(1,45)=5.36, P=.03, B=–640.71, 95% CI –1198.30 to –83.11) and positively associated with the login frequency of the entire BCS program (F(1,45)=10.86, P=.002, B=192.88, 95% CI 75.01-310.74). No statistical differences were found between BCS usage data and cancer stage, BMI, comorbidity, types of surgery, or cycles of chemotherapy. CONCLUSIONS: Overall, this study found considerable variability in the usage of app-based interventions. When health care professionals incorporate app-based interventions into their routine care for women with breast cancer, the learning and discussion functions of apps should be strengthened to promote engagement. Additionally, characteristics of women with breast cancer, such as age, level of education, income, and employment status, should be taken in consideration to develop tailored apps that address their particular needs and therefore improve their engagement with the app. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry ACTRN12616000639426; http://www.ANZCTR.org.au/ACTRN12616000639426.aspx JMIR Publications 2020-09-16 /pmc/articles/PMC7527913/ /pubmed/32936087 http://dx.doi.org/10.2196/18896 Text en ©Haihua Zhu, Xiuwan Chen, Jinqiu Yang, Qiaoling Wu, Jiemin Zhu, Sally Wai-Chi Chan. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 16.09.2020. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR mHealth and uHealth, is properly cited. The complete bibliographic information, a link to the original publication on http://mhealth.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
Zhu, Haihua
Chen, Xiuwan
Yang, Jinqiu
Wu, Qiaoling
Zhu, Jiemin
Chan, Sally Wai-Chi
Mobile Breast Cancer e-Support Program for Chinese Women With Breast Cancer Undergoing Chemotherapy (Part 3): Secondary Data Analysis
title Mobile Breast Cancer e-Support Program for Chinese Women With Breast Cancer Undergoing Chemotherapy (Part 3): Secondary Data Analysis
title_full Mobile Breast Cancer e-Support Program for Chinese Women With Breast Cancer Undergoing Chemotherapy (Part 3): Secondary Data Analysis
title_fullStr Mobile Breast Cancer e-Support Program for Chinese Women With Breast Cancer Undergoing Chemotherapy (Part 3): Secondary Data Analysis
title_full_unstemmed Mobile Breast Cancer e-Support Program for Chinese Women With Breast Cancer Undergoing Chemotherapy (Part 3): Secondary Data Analysis
title_short Mobile Breast Cancer e-Support Program for Chinese Women With Breast Cancer Undergoing Chemotherapy (Part 3): Secondary Data Analysis
title_sort mobile breast cancer e-support program for chinese women with breast cancer undergoing chemotherapy (part 3): secondary data analysis
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527913/
https://www.ncbi.nlm.nih.gov/pubmed/32936087
http://dx.doi.org/10.2196/18896
work_keys_str_mv AT zhuhaihua mobilebreastcanceresupportprogramforchinesewomenwithbreastcancerundergoingchemotherapypart3secondarydataanalysis
AT chenxiuwan mobilebreastcanceresupportprogramforchinesewomenwithbreastcancerundergoingchemotherapypart3secondarydataanalysis
AT yangjinqiu mobilebreastcanceresupportprogramforchinesewomenwithbreastcancerundergoingchemotherapypart3secondarydataanalysis
AT wuqiaoling mobilebreastcanceresupportprogramforchinesewomenwithbreastcancerundergoingchemotherapypart3secondarydataanalysis
AT zhujiemin mobilebreastcanceresupportprogramforchinesewomenwithbreastcancerundergoingchemotherapypart3secondarydataanalysis
AT chansallywaichi mobilebreastcanceresupportprogramforchinesewomenwithbreastcancerundergoingchemotherapypart3secondarydataanalysis